Altamira Therapeutics Ltd. at its Annual General Meeting of Shareholders held on May 16, 2024, elected Dominik Lysek as member of the Board of Directors, each for a term of one year ending upon completion of the 2025 Annual General Meeting (or until their respective successors are elected).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | 0.00% |
|
+9.91% | -64.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.94% | 2.53M | |
+16.89% | 121B | |
+17.59% | 110B | |
+17.23% | 25.98B | |
-24.48% | 19.27B | |
-18.56% | 15.99B | |
-18.23% | 15.66B | |
-47.75% | 14.5B | |
+57.08% | 14.47B | |
+4.98% | 13.91B |
- Stock Market
- Equities
- CYTO Stock
- News Altamira Therapeutics Ltd.
- Altamira Therapeutics Ltd. Elects Dominik Lysek as Member of Board of Directors